Congress Year-End Legislative Package Delivers for the Rare Community
These measures follow the successful passage of H.R. 6833 in October, which included a five-year reauthorization of critical FDA user-fee programs that help ensure rare disease patients gain timely access to essential therapies and diagnostic tools.
United States Peter Saltonstall National Organization For Rare Disorders National Institutes Of Health Children Health Insurance Program Drug Administration
Source: pressreleasepoint.com